INSM
Price
$73.50
Change
+$0.06 (+0.08%)
Updated
Apr 3, 02:44 PM (EDT)
Capitalization
13.29B
28 days until earnings call
SRPT
Price
$62.47
Change
+$0.56 (+0.90%)
Updated
Apr 2 closing price
Capitalization
6.06B
27 days until earnings call
Ad is loading...

INSM vs SRPT

Header iconINSM vs SRPT Comparison
Open Charts INSM vs SRPTBanner chart's image
Insmed
Price$73.50
Change+$0.06 (+0.08%)
Volume$2.92K
Capitalization13.29B
Sarepta Therapeutics
Price$62.47
Change+$0.56 (+0.90%)
Volume$3.8M
Capitalization6.06B
INSM vs SRPT Comparison Chart
Loading...
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INSM vs. SRPT commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INSM is a Hold and SRPT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (INSM: $73.44 vs. SRPT: $62.47)
Brand notoriety: INSM: Not notable vs. SRPT: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INSM: 133% vs. SRPT: 229%
Market capitalization -- INSM: $13.29B vs. SRPT: $6.06B
INSM [@Biotechnology] is valued at $13.29B. SRPT’s [@Biotechnology] market capitalization is $6.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INSM’s FA Score shows that 1 FA rating(s) are green whileSRPT’s FA Score has 0 green FA rating(s).

  • INSM’s FA Score: 1 green, 4 red.
  • SRPT’s FA Score: 0 green, 5 red.
According to our system of comparison, INSM is a better buy in the long-term than SRPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INSM’s TA Score shows that 4 TA indicator(s) are bullish while SRPT’s TA Score has 4 bullish TA indicator(s).

  • INSM’s TA Score: 4 bullish, 5 bearish.
  • SRPT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SRPT is a better buy in the short-term than INSM.

Price Growth

INSM (@Biotechnology) experienced а -4.09% price change this week, while SRPT (@Biotechnology) price change was -14.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.84%. For the same industry, the average monthly price growth was -9.88%, and the average quarterly price growth was -14.17%.

Reported Earning Dates

INSM is expected to report earnings on May 01, 2025.

SRPT is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (-7.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INSM($13.3B) has a higher market cap than SRPT($6.06B). INSM YTD gains are higher at: 6.373 vs. SRPT (-48.622). SRPT has higher annual earnings (EBITDA): 317M vs. INSM (-818.79M). INSM has more cash in the bank: 1.43B vs. SRPT (1.36B). INSM has less debt than SRPT: INSM (1.15B) vs SRPT (1.34B). SRPT has higher revenues than INSM: SRPT (1.9B) vs INSM (364M).
INSMSRPTINSM / SRPT
Capitalization13.3B6.06B219%
EBITDA-818.79M317M-258%
Gain YTD6.373-48.622-13%
P/E RatioN/A26.70-
Revenue364M1.9B19%
Total Cash1.43B1.36B106%
Total Debt1.15B1.34B86%
FUNDAMENTALS RATINGS
INSM vs SRPT: Fundamental Ratings
INSM
SRPT
OUTLOOK RATING
1..100
7760
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
70
Overvalued
PROFIT vs RISK RATING
1..100
18100
SMR RATING
1..100
10046
PRICE GROWTH RATING
1..100
4095
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SRPT's Valuation (70) in the Biotechnology industry is in the same range as INSM (87). This means that SRPT’s stock grew similarly to INSM’s over the last 12 months.

INSM's Profit vs Risk Rating (18) in the Biotechnology industry is significantly better than the same rating for SRPT (100). This means that INSM’s stock grew significantly faster than SRPT’s over the last 12 months.

SRPT's SMR Rating (46) in the Biotechnology industry is somewhat better than the same rating for INSM (100). This means that SRPT’s stock grew somewhat faster than INSM’s over the last 12 months.

INSM's Price Growth Rating (40) in the Biotechnology industry is somewhat better than the same rating for SRPT (95). This means that INSM’s stock grew somewhat faster than SRPT’s over the last 12 months.

INSM's P/E Growth Rating (100) in the Biotechnology industry is in the same range as SRPT (100). This means that INSM’s stock grew similarly to SRPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INSMSRPT
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
69%
Momentum
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
73%
MACD
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 7 days ago
72%
Bullish Trend 11 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
66%
View a ticker or compare two or three
Ad is loading...
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TDVI22.540.16
+0.71%
FT Vest Tech Div Trgt Inc ETF
DXJ109.600.35
+0.32%
WisdomTree Japan Hedged Equity ETF
AVIV56.850.12
+0.21%
Avantis International Large Cap Val ETF
USDU27.180.03
+0.11%
WisdomTree Bloomberg US Dllr Bullish ETF
NIKL8.88-0.04
-0.45%
Sprott Nickel Miners ETF

INSM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INSM has been closely correlated with THAR. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if INSM jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSM
1D Price
Change %
INSM100%
+2.00%
THAR - INSM
74%
Closely correlated
+0.78%
SRPT - INSM
44%
Loosely correlated
+0.90%
AGIO - INSM
43%
Loosely correlated
+3.80%
VERA - INSM
41%
Loosely correlated
+7.13%
AXON - INSM
40%
Loosely correlated
+3.18%
More